company background image

Mouwasat Medical Services SASE:4002 Stock Report

Last Price


Market Cap







29 Sep, 2022


Company Financials +
4002 fundamental analysis
Snowflake Score
Future Growth4/6
Past Performance3/6
Financial Health6/6

4002 Stock Overview

Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia.


Trading at 28.4% below our estimate of its fair value

Earnings are forecast to grow 13.62% per year

Risk Analysis

No risks detected for 4002 from our risk checks.

Mouwasat Medical Services Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mouwasat Medical Services
Historical stock prices
Current Share Priceر.س198.00
52 Week Highر.س259.40
52 Week Lowر.س158.80
1 Month Change-16.88%
3 Month Change-7.04%
1 Year Change9.39%
3 Year Change125.00%
5 Year Change147.19%
Change since IPO1,277.39%

Recent News & Updates

Aug 24
Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...

Jul 01
A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Does the July share price for Mouwasat Medical Services Company ( TADAWUL:4002 ) reflect what it's really worth? Today...

Shareholder Returns

4002SA HealthcareSA Market

Return vs Industry: 4002 underperformed the SA Healthcare industry which returned 19.3% over the past year.

Return vs Market: 4002 exceeded the SA Market which returned 2.4% over the past year.

Price Volatility

Is 4002's price volatile compared to industry and market?
4002 volatility
4002 Average Weekly Movement4.9%
Healthcare Industry Average Movement4.4%
Market Average Movement4.5%
10% most volatile stocks in SA Market7.3%
10% least volatile stocks in SA Market2.8%

Stable Share Price: 4002 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 4002's weekly volatility (5%) has been stable over the past year.

About the Company

1974n/aNasser Sultan Al-Subaie

Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. It operates a network of hospitals in Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh that provides a range of medical services. The company also operates skin care centers, which offer laser, cosmetic dermatological, reconstructive surgery, beauty, clinical dermatology, plastic surgery, weight loss, and other medical cosmetic services; a fertility center; and a clinic for bariatric surgery.

Mouwasat Medical Services Fundamentals Summary

How do Mouwasat Medical Services's earnings and revenue compare to its market cap?
4002 fundamental statistics
Market Capر.س19.82b
Earnings (TTM)ر.س581.32m
Revenue (TTM)ر.س2.21b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4002 income statement (TTM)
Cost of Revenueر.س1.20b
Gross Profitر.س1.01b
Other Expensesر.س425.25m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)5.81
Gross Margin45.58%
Net Profit Margin26.33%
Debt/Equity Ratio34.0%

How did 4002 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is 4002 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4002?

Other financial metrics that can be useful for relative valuation.

4002 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue9.4x
Enterprise Value/EBITDA26.6x
PEG Ratio2.5x

Price to Earnings Ratio vs Peers

How does 4002's PE Ratio compare to its peers?

4002 PE Ratio vs Peers
The above table shows the PE ratio for 4002 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average39.2x
4004 Dallah Healthcare
4007 Al Hammadi Holding
4013 Dr. Sulaiman Al Habib Medical Services Group
4005 National Medical Care
4002 Mouwasat Medical Services

Price-To-Earnings vs Peers: 4002 is good value based on its Price-To-Earnings Ratio (34.1x) compared to the peer average (39.2x).

Price to Earnings Ratio vs Industry

How does 4002's PE Ratio compare vs other companies in the Asian Healthcare Industry?

Price-To-Earnings vs Industry: 4002 is expensive based on its Price-To-Earnings Ratio (34.1x) compared to the Asian Healthcare industry average (17.4x)

Price to Earnings Ratio vs Fair Ratio

What is 4002's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4002 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio34.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4002's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 4002 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4002 (SAR198) is trading below our estimate of fair value (SAR276.65)

Significantly Below Fair Value: 4002 is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Future Growth

How is Mouwasat Medical Services forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

Future Growth Score


Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4002's forecast earnings growth (13.6% per year) is above the savings rate (8.9%).

Earnings vs Market: 4002's earnings (13.6% per year) are forecast to grow faster than the SA market (-2.8% per year).

High Growth Earnings: 4002's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4002's revenue (10.4% per year) is forecast to grow faster than the SA market (-5.3% per year).

High Growth Revenue: 4002's revenue (10.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4002's Return on Equity is forecast to be high in 3 years time (23.7%)

Discover growth companies

Past Performance

How has Mouwasat Medical Services performed over the past 5 years?

Past Performance Score


Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4002 has high quality earnings.

Growing Profit Margin: 4002's current net profit margins (26.3%) are lower than last year (27.7%).

Past Earnings Growth Analysis

Earnings Trend: 4002's earnings have grown by 14.6% per year over the past 5 years.

Accelerating Growth: 4002's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4002 had negative earnings growth (-2%) over the past year, making it difficult to compare to the Healthcare industry average (-2.5%).

Return on Equity

High ROE: 4002's Return on Equity (22.8%) is considered high.

Discover strong past performing companies

Financial Health

How is Mouwasat Medical Services's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4002's short term assets (SAR1.4B) exceed its short term liabilities (SAR782.9M).

Long Term Liabilities: 4002's short term assets (SAR1.4B) exceed its long term liabilities (SAR801.9M).

Debt to Equity History and Analysis

Debt Level: 4002's net debt to equity ratio (31.9%) is considered satisfactory.

Reducing Debt: 4002's debt to equity ratio has reduced from 37.2% to 34% over the past 5 years.

Debt Coverage: 4002's debt is well covered by operating cash flow (59%).

Interest Coverage: 4002's interest payments on its debt are well covered by EBIT (107.8x coverage).

Balance Sheet

Discover healthy companies


What is Mouwasat Medical Services's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Dividend Yield vs Market

Mouwasat Medical Services Dividend Yield vs Market
How does Mouwasat Medical Services dividend yield compare to the market?
SegmentDividend Yield
Company (Mouwasat Medical Services)1.4%
Market Bottom 25% (SA)2.0%
Market Top 25% (SA)4.7%
Industry Average (Healthcare)1.6%
Analyst forecast in 3 Years (Mouwasat Medical Services)1.8%

Notable Dividend: 4002's dividend (1.39%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (2.05%).

High Dividend: 4002's dividend (1.39%) is low compared to the top 25% of dividend payers in the SA market (4.67%).

Stability and Growth of Payments

Stable Dividend: 4002's dividends per share have been stable in the past 10 years.

Growing Dividend: 4002's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (47.3%), 4002's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (169.6%), 4002's dividend payments are not well covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Nasser Sultan Al-Subaie (67 yo)

no data


Mr. Nasser Sultan Al-hammad Al-subaie serves as the Chief Executive Officer and Vice Chairman of Al-Mouwasat Medical Services Company. Mr. Al-subaie holds a Certificate in managing health organizations fro...


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 4002?
Owner TypeNumber of SharesOwnership Percentage
General Public41,085,90241.1%
Individual Insiders52,515,45352.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 58.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
Mohammed Al-Saleem
17,504,760SAR3.5b0%no data
Mohammed Al-Subaie
17,500,000SAR3.5b0%no data
Nasser Sultan Al-Subaie
17,500,000SAR3.5b0%no data
The Vanguard Group, Inc.
1,920,410SAR380.2m1.23%no data
BlackRock, Inc.
1,372,525SAR271.8m-1.7%no data
J.P. Morgan Asset Management, Inc.
Geode Capital Management, LLC
393,549SAR77.9m-2.48%no data
Dimensional Fund Advisors LP
272,949SAR54.0m-1.07%no data
Teachers Insurance and Annuity Association-College Retirement Equities Fund
270,153SAR53.5m21.61%no data
Franklin Resources, Inc.
174,805SAR34.6m0.11%no data
State Street Global Advisors, Inc.
95,310SAR18.9m-4.56%no data
CIBC Asset Management Inc.
T. Rowe Price Group, Inc.
76,117SAR15.1m-6.74%no data
Northern Trust Global Investments
72,811SAR14.4m-0.16%no data
Charles Schwab Investment Management, Inc.
66,464SAR13.2m0.89%no data
Putnam LLC
Calamos Asset Management, Inc.
William Blair Investment Management, LLC
Jupiter Fund Management Plc
Emirates NBD Asset Management Limited
UBS Asset Management
52,230SAR10.3m-6.39%no data
Harding Loevner LP
Boston Partners Global Investors, Inc.
49,075SAR9.7m0%no data
Amundi Asset Management
48,480SAR9.6m-2.72%no data
Victory Capital Management Inc.
47,906SAR9.5m0%no data

Company Information

Mouwasat Medical Services Company's employee growth, exchange listings and data sources

Key Information

  • Name: Mouwasat Medical Services Company
  • Ticker: 4002
  • Exchange: SASE
  • Founded: 1974
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: ر.س19.820b
  • Shares outstanding: 100.00m
  • Website:


  • Mouwasat Medical Services Company
  • Destect 71 - King Fahad Road
  • PO Box 282
  • Dammam
  • 31411
  • Saudi Arabia


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
4002SASE (Saudi Arabian Stock Exchange)YesOrdinary SharesSASARSep 2009

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/29 00:00
End of Day Share Price2022/09/29 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.